Wilcox, M. H. Et Al. 2017. Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection. NEW ENGLAND JOURNAL OF MEDICINE , vol.376, no.4 , 305-317.

Wilcox, M. H., Gerding, D. N., Poxton, I. R., Kelly, C., Nathan, R., Birch, T., ... Cornely, O. A.(2017). Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection. NEW ENGLAND JOURNAL OF MEDICINE , vol.376, no.4, 305-317.

Wilcox, M. Et Al. "Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection," NEW ENGLAND JOURNAL OF MEDICINE , vol.376, no.4, 305-317, 2017

Wilcox, M. H. Et Al. "Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection." NEW ENGLAND JOURNAL OF MEDICINE , vol.376, no.4, pp.305-317, 2017

Wilcox, M. H. Et Al. (2017) . "Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection." NEW ENGLAND JOURNAL OF MEDICINE , vol.376, no.4, pp.305-317.

@article{article, author={M. H. Wilcox Et Al. }, title={Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection}, journal={NEW ENGLAND JOURNAL OF MEDICINE}, year=2017, pages={305-317} }